Women's health therapeutic (1) - Avion Pharmaceuticals
Latest Information Update: 10 Sep 2016
At a glance
- Originator Unknown
- Developer Avion Pharmaceuticals
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Female genital diseases
Most Recent Events
- 09 Sep 2016 No recent reports on development identified - Clinical-Phase-Unknown for Gynaecological disorders in USA (unspecified route)
- 16 Jun 2014 Clinical trials in Gynaecological disorders in USA (unspecified route) before June 2014